Document Detail

Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis.
Jump to Full Text
MedLine Citation:
PMID:  25090937     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Cardiac involvement is a relevant clinical finding in systemic sclerosis (SSc) and is associated with poor prognosis. Left atrial (LA) remodeling and/or dysfunction can be an early sign of diastolic dysfunction. Two-dimensional speckle tracking echocardiography (STE) is a novel and promising tool for detecting very early changes in LA myocardial performance.Aim: To assess whether STE strain parameters may detect early alterations in LA function in SSc patients.
METHODS: Forty-two SSc patients (Group 1, age 50 +/- 14 years, 95% females) without clinical evidence for cardiac involvement and 42 age- and gender-matched control subjects (Group 2, age 49 +/- 13 years, 95% females) were evaluated with comprehensive 2D and Doppler echocardiography, including tissue Doppler imaging analysis. Positive peak left atrial longitudinal strain (epsilon pos peak), second positive left atrial longitudinal strain (sec epsilon pos peak), and negative left atrial longitudinal strain (epsilon neg peak) were measured using a 12-segment model for the LA, by commercially available semi-automated 2D speckle-tracking software (EchoPac PC version 108.1.4, GE Healthcare, Horten, Norway).
RESULTS: All SSc patients had a normal left ventricular ejection fraction (63.1 +/- 4%). SSc patients did not differ from controls in E/A (Group 1 = 1.1 +/- 0.4 vs Group 2 = 1.3 +/- 0.4, p = .14) or pulmonary arterial systolic pressure (Group 1 = 24.1 +/- 8 mmHg vs Group 2 = 21 +/- 7 mmHg, p = .17). SSc patients did not show significantly different indexed LA volumes (Group 1 = 24.9 +/- 5.3 ml/m2 vs Group 2 = 24.7 +/- 4.4 ml/m2, p = .8), whereas E/e' ratio was significantly higher in SSc (Group 1 = 7.6 +/- 2.4 vs Group 2 = 6.5 +/- 1.7, p[modifier letter left arrowhead]0.05), although still within normal values. LA strain values were significantly different between the two groups (epsilon pos peak Group 1 = 31.3 +/- 4.2% vs Group 2 = 35.0 +/- 7.6%, p < .01, sec epsilon pos peak Group 1 = 18.4 +/- 4 vs Group 2 = 21.4 +/- 7.6, p < 0.05).
CONCLUSION: 2D speckle-tracking echocardiography is a sensitive tool to assess impairment of LA mechanics, which is detectable in absence of changes in LA size and volume, and may represent an early sign of cardiac involvement in patients with SSc.
Authors:
Gergely Agoston; Luna Gargani; Marcelo Haertel Miglioranza; Maria Caputo; Luigi Paolo Badano; Antonella Moreo; Denisa Muraru; Sergio Mondillo; Alberto Moggi Pignone; Marco Matucci Cerinic; Rosa Sicari; Eugenio Picano; Albert Varga
Related Documents :
99307 - The dependence of t wave alternans on diastolic resting period duration.
3621947 - R wave amplitude changes during transoesophageal atrial pacing in patients with chronic...
23358827 - Can cardiac rehabilitation programs improve functional capacity and left ventricular di...
3171457 - Electrovectorcardiographic study of negative t waves on precordial leads in arrhythmoge...
15851327 - The inward rectifier current (ik1) controls cardiac excitability and is involved in arr...
2517307 - Av nodal reentrant tachycardia with mahaim fiber conduction.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-5
Journal Detail:
Title:  Cardiovascular ultrasound     Volume:  12     ISSN:  1476-7120     ISO Abbreviation:  Cardiovasc Ultrasound     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101159952     Medline TA:  Cardiovasc Ultrasound     Country:  -    
Other Details:
Languages:  ENG     Pagination:  30     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Cardiovasc Ultrasound
Journal ID (iso-abbrev): Cardiovasc Ultrasound
ISSN: 1476-7120
Publisher: BioMed Central
Article Information
Download PDF
Copyright © 2014 Agoston et al.; licensee BioMed Central Ltd.
open-access:
Received Day: 1 Month: 5 Year: 2014
Accepted Day: 28 Month: 7 Year: 2014
collection publication date: Year: 2014
Electronic publication date: Day: 5 Month: 8 Year: 2014
Volume: 12First Page: 30 Last Page: 30
PubMed Id: 25090937
ID: 4134332
Publisher Id: 1476-7120-12-30
DOI: 10.1186/1476-7120-12-30

Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis
Gergely Agoston1 Email: drgergoagoston@gmail.com
Luna Gargani2 Email: lunagargani@gmail.com
Marcelo Haertel Miglioranza34 Email: marcelohaertel@gmail.com
Maria Caputo5 Email: marialuce@skarabeo.net
Luigi Paolo Badano3 Email: lpbadano@gmail.com
Antonella Moreo6 Email: Antonella.Moreo@ospedaleniguarda.it
Denisa Muraru3 Email: denisa.muraru@gmail.com
Sergio Mondillo5 Email: mondillo@unisi.it
Alberto Moggi Pignone7 Email: pignone@unifi.it
Marco Matucci Cerinic8 Email: cerinic@unifi.it
Rosa Sicari2 Email: rosas@ifc.cnr.it
Eugenio Picano2 Email: picano@ifc.cnr.it
Albert Varga1 Email: vargaa@in2nd.szote.u-szeged.hu
12nd Department of Medicine and Cardiology Center, University of Szeged, Korányi Fasor 6, 6720 Szeged, Hungary
2Institute of Clinical Physiology, National Council of Research, Pisa, Italy
3Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padua, Italy
4Cardiology Institute of Rio Grande do Sul, Porto Alegre, Brazil
5Department of Cardiovascular Diseases, University of Siena, Siena, Italy
6Cardiology Department, Niguarda Ca’ Granda Hospital, Milan, Italy
7Department of Internal Medicine, University of Florence, Florence, Italy
8Department of Biomedicine, Division of Rheumatology, University of Florence, Florence, Italy

Introduction

Systemic sclerosis (SSc) is a chronic, systemic connective tissue disease characterized by inflammation and fibrosis involving various organs, including the skin, lungs, gastrointestinal tract, kidneys and heart. Although cardiac involvement is often clinically asymptomatic [1], it occurs in a significant percentage of patients [2,3]. All cardiac structures - endocardium, myocardium, pericardium, valves, coronary arteries, electrical and nervous system - may be involved, potentially leading to heart failure. Primary myocardial involvement, without systemic or pulmonary hypertension and without significant renal or pulmonary involvement, implicates different pathophysiological mechanisms, including the characteristic vascular lesions and fibrosis deposition, which may impair coronary microcirculation and myocardial function, and is one of the leading causes of mortality in these patients [4]. Systolic and/or diastolic dysfunction can develop very early in the course of the disease, even years before becoming clinically relevant, and are recognized as very powerful adverse prognostic factors [5]. Preclinical identification of cardiac involvement is pivotal for adequate early management of these patients.

Left atrial (LA) volume, as an LA functional index, has recently been identified as a potential marker of cardiac involvement and atrial arrhythmias [6]. Changes in LA volumes and mechanics have been demonstrated in patients with rheumatic disease, and can even precede the involvement of the ventricles [7,8]. Recently, the assessment of LA deformation profiles obtained by deformation imaging has been proposed as an alternative method of exploring LA function and to detect early changes in LA myocardial performance [9,10]. Our aim was to evaluate LA function in SSc patients by two-dimensional speckle tracking echocardiography (STE) strain parameters.


Methods
Study population

From September 2009 to January 2010, 42 consecutive patients affected with SSc (Group 1, age 50 ± 14 years, 95% females) admitted to the Rheumatology Clinic of Florence, and 42 age and gender-matched control subjects (Group 2, age 49 ± 13 years, and 95% females) were enrolled. Patients in Group 1 underwent a thorough clinical characterization, including a modified Rodnan skin score [11], pulmonary function test [12], assessment of pulmonary fibrosis by standard chest X-ray, lung ultrasound [13] and, when clinically indicated, by thoracic high-resolution computed tomography scan [14]. Inclusion criteria were: 1) age > 18 and < 85 years; 2) a previous diagnosis of SSc according to the American Rheumatism Association classification criteria for SSc [15]. Exclusion criteria were: 1) inability to provide informed consent; 2) known history of coronary artery disease, electrocardiographic signs of myocardial ischemia, left ventricular ejection fraction <55%, regional wall motion abnormalities, left ventricular hypertrophy, more than mild valvular heart disease, pericardial effusion, and evidence or clear history of atrial fibrillation, inadequate LA tracking for strain analysis. Anticentromere antibodies (ACA by indirect immunofluorescence on Hep-2 cells and by ELISA for CENP antigen) and antitopoisomerase I antibodies (anti-Scl70 by immunoblot analysis) were determined. All operators were unaware of the results of the other tests. The local Ethical Committee of Pisa, Italy, protocol number 2849 approved and all patients gave informed consent.

Echocardiography

All patients underwent comprehensive two-dimensional transthoracic echocardiography examinations at rest, using conventional methods with a commercially available ultrasound machine (Vivid 7, GE Medical Systems, Horten, Norway) equipped with a 2.5-3.5 MHz phased-array sector scan probe, second harmonic technology, and coupled with tissue Doppler imaging (TDI). Left ventricular (LV) end-diastolic and end-systolic diameters were measured from the internal dimensions obtained from parasternal long axis view. LA diameters were measured from the apical four-chamber view. LA areas and volumes were measured using the biplane method of disks (modified Simpson’s rule), in the apical 4- and 2-chamber view at end-systole (maximum LA size), and a mean value of area and volume was obtained [16]. LA volumes were subsequently indexed to body surface area (BSA). LV mass was calculated by the Devereux formula and then indexed to body surface area [16]. Mitral regurgitation was assessed semi-quantitatively (0 = absent or trivial, 1 = mild, 2 = moderate, 3 = severe), including evaluation of vena contracta, regurgitant volume and effective regurgitant orifice area, when indicated [17]. TDI was evaluated, as previously described, in the pulsed-wave Doppler mode, to assess longitudinal myocardial regional LV function. A volume was sampled centrally to the basal segment of infero-septal and antero-lateral wall for the LV, and then the mean value of the velocity profiles was recorded. Gain and filters were adjusted as needed, to eliminate background noise and to obtain a clear tissue signal. TDI signals were recorded at a sweep of 100 mm/s. Each parameter was measured as the average of at least three consecutive beats. LV diastolic function was determined from the pattern of mitral flow velocity by pulsed Doppler echocardiography, complemented by mitral annular velocity by TDI and LA volumes. Diastolic dysfunction was graded as “absent” (grade 0), “mild” (grade 1, impaired relaxation), “moderate” (grade 2, pseudonormalized filling pattern), and “severe” (grade 3, restrictive filling pattern) [18]. Pulmonary artery systolic pressure (PASP) was estimated from peak tricuspid regurgitation jet velocities, adding right atrial pressure estimated from inferior vena cava diameter and respiratory changes [19]. All measurements were performed according to the recommendations of the European Association of Echocardiography/American Society of Echocardiography [16-20].

Assessment of the left atrial function

Particular attention was paid to obtaining an adequate grayscale image, allowing reliable delineation of myocardial tissue and extracardiac structures. During breath hold, 3 consecutive heart cycles were recorded and averaged. The frame rate was set between 60 and 80 frames per second. These settings are recommended to combine temporal resolution with adequate spatial definition, and to enhance the feasibility of the frame-to frame tracking technique [21]. Recordings were processed using acoustic-tracking software (EchoPac PC version 108.1.4, GE Healthcare, Horten, Norway), allowing off-line semi-automated analysis of STE strain. In the end-diastolic/systolic frame, the atrial endocardial border was traced by a point-and-click method. After automatic creation of a region of interest, the LA wall was divided into six subregions, and segmental tracking quality was analyzed. We analyzed LA from apical two- and four-chamber views, so we used a 12-segment model. The dashed curve represents the average strain (Figure 1). The tracking settings allow distinguishing three LA strain values. If the reference point is set at the onset of the QRS, we can measure positive peak atrial longitudinal strain (ϵ pos peak), which corresponds to LA reservoir function (Figure 1). If the reference point is set at the onset of the P wave, we can measure both negative atrial longitudinal strain (ϵ neg peak), which mirrors LA pump function and second positive peak atrial strain (sec ϵ pos peak), which corresponds to LA conduit function [21] (Figure 2). Inter- and intra-observer variability of strain parameters has been previously assessed [9].

Statistical analysis

Data are presented as mean ± standard deviation (SD) unless otherwise stated. Comparisons between SSc patients and controls were performed using Student’s t-tests or by non-parametric Mann–Whitney U-test, as appropriate. Comparisons between categorical variables were made with χ2 test. All tests were two-sided and p-values < .05 were considered statistically significant. Correlations were tested by Pearson or Spearman’s correlation tests, as appropriate. All analyses were performed using SPSS 20.0.0 (IBM Inc, Chicago, IL, USA) and GraphPad Prism version 6 (GraphPad Software Inc., San Diego, CA, USA).


Results

The clinical and echocardiographic characteristics of Groups 1 and 2 are summarized in Tables 1 and 2. From the initial population of 55 patients, 7 were excluded for inadequate LA tracking quality, and 6 were excluded for the evidence of cardiac abnormalities (2 patients for EF < 55%, 3 patients for pericardial effusion, 1 patient for LV hypertrophy). Two patients in Group 1 had more than 1 cardiovascular risk factors (1 with arterial hypertension and smoking habit, and 1 with arterial hypertension and diabetes mellitus); Group 2 included 3 patients with concomitant arterial hypertension and dyslipidemia. The two groups did not differ in systolic function of the left ventricle (Group 1 EF = 63.1 ± 4%, vs Group 2 = 66.1 ± 4%, p = ns). SSc patients did not show significantly different LA indexed volumes (Group 1 = 24.9 ± 5.3 ml/m2 vs Group 2 = 24.7 ± 4.4 ml/m2, p = .8, Figure 3), but showed significantly different LV diastolic and LA longitudinal strain parameters. E/e’ ratio was higher in SSc patients (Group 1 = 7.6 ± 2.4 vs Group 2 = 6.5 ± 1.7, p < .05, Figure 4) and ϵ pos peak and sec ϵ pos peak were significantly decreased (Group 1 = 31.3 ± 4.2% vs Group 2 = 35.0 ± 7.6%, p < .01 and Group 1 = 18.4 ± 4% vs Group 2 = 21.4 ± 7.6%, p < .05) (Figure 5). ϵ neg peak did not show significant differences (Group 1 = -12.9 ± 2% vs Group 2 = -13.6 ± 3%, p = ns). Interestingly, we found a significant correlation between ϵ pos peak and age, but only in the control group (R = -.59, p < .001) and not in SSc patients (R = -.09, p = .57). Among echocardiographic parameters, no correlations were found between LA ϵ pos peak and LV EF, nor E/e’, or LA indexed volume or PASP. No significant differences in LA ϵ pos peak values were found between patients with and without Scl-70 antibodies (31.1 ± 4.2% vs 30.6 ± 4.1%, p = .75), nor between patients with limited and diffuse form (31.7 ± 3.9% vs 29.9 ± 5.7%, p = .79). No echocardiographic, STE or clinical parameter (including diffusing capacity for carbon monoxide) was significantly different between patients in NYHA class I and NYHA class II-III, nor between patients with normal and abnormal NT-proBNP values (only a trend in higher PASP was found in patients with abnormal NT-proBNP values: 18.7 ± 4.6 vs 25.3 ± 8.1 mmHg, p = .07).


Discussion

Our data show that SSc patients with normal left ventricular systolic function and without any significant cardiac abnormalities have reduced LA STE values, compared to a control group. STE may be a non-invasive, feasible method to assess early LA dysfunction in SSc patients. Such cardiac mechanic alterations are detectable in absence of changes in LA size.

Pathophysiological mechanisms of LA dysfunction in SSc

The LA is a reservoir, a conduit and a pump, which plays an important role in modulating LV filling [22,23]. According to the Frank-Starling law, the LA pump function increases in the presence of mild LV diastolic dysfunction and then significantly decreases when LV diastolic dysfunction progresses to moderate or severe degrees [22-24]. Global LA function parameters, such as LA dimensions, area and volume, are good prognostic markers for predicting LV diastolic dysfunction [25,26]. However, an impairment of these parameters may appear late in the course of the disease. STE provides early, detailed information about LA mechanics. Several papers demonstrated the usefulness of STE in assessing LA function [10,27-30]. Inaba Y et al. showed that LA strain rate correlate with age, LA size and diastolic dysfunction in patients with atrial fibrillation [27]. LA strain rate was also an accurate predictor of recovery of LA contractility after cardioversion [28] and LA ϵ pos peak was a significant predictor of postoperative atrial fibrillation in patients undergoing aortic valve replacement [29].

In SSc, the myocardium is often characterized by patchy fibrosis, secondary to both repeated ischemia and/or immuno-inflammatory damage, inexorably leading to diastolic dysfunction. Episodes of ischemia in SSc are usually not due to epicardial coronary artery stenosis, but rather to microvascular dysfunction [31], since characteristic SSc vascular lesions result in major impairment of the microcirculation [4]. In addition to these fixed abnormalities, vasospasm of the small coronary arteries or arterioles may play a significant role in the early myocardial alterations in SSc [32]. Diastolic dysfunction is frequent in SSc [33-35], and is correlated with disease duration [36], whereas systolic dysfunction is present in only a minority of SSc patients [37]. Myocardial fibrosis in SSc has been reported in 50–80% of necropsy series [38-44], however the diagnosis of myocardial fibrosis can be challenging by non-invasive imaging. Up-to-now MRI is considered as the non-invasive gold standard imaging technique to assess myocardial fibrosis. Previous studies observed high percentages of myocardial fibrosis at MRI through detection of late gadolinium enhancement, although with different prevalence [38-44]. In a recent study, Ntusi et al. [45] found that although biventricular size and global function were preserved, there was impairment in the peak systolic circumferential and peak diastolic strain rate of the left ventricle, which inversely correlated with diffuse myocardial fibrosis indices at MRI.

Clinical implications

Characterization of the LA has important prognostic implications [46,47]. LA enlargement is known to be associated with increased mortality in the general population [26]. Impaired LA function might be also an important predictor for the development of nonvalvular atrial fibrillation or other supraventricular arrhythmias [48], which are not infrequent in SSc patients. In our population, no patients had atrial fibrillation or other significant supraventricular arrhytmias. It would be interesting to see whether LA dysfunction can predict the development of supraventricular arrhythmias in this population.

In our study the LA reservoir (ϵ pos peak) and conduit (sec ϵ pos peak) function are impaired compared to controls. We may speculate that myocardial involvement and changes in the extracellular matrix may lead to early dysfunction of LA, even before the LA starts to dilate, since there was no difference between LA volume in the two groups. Early alternations of LA function can also mirror LV involvement in SSc. Myocardial fibrosis and consequent left ventricular diastolic dysfunction leads to the decrease of LA reservoir and conduit function and to the increase of LA pump function (Frank-Starling law).

The clinical meaning of an early assessment of LA mechanics in SSc by STE is still undetermined, and follow-up studies with a larger number of patients are needed to evaluate whether this finding has any prognostic implication. However, the use of a non-invasive, non-ionizing, and relatively simple method that lets us track LA function characteristics over time is intriguing. Speckle tracking allows a very sensitive estimation and monitoring of LA mechanics that may help us understand the progressive steps in the ongoing pathophysiological process leading to overt myocardial dysfunction. STE measurement has demonstrated to correlate also with the extent of LA fibrosis and remodeling [49]. This new echocardiographic analysis of LA function might also be employed as a biomarker in therapeutic trials, to assess efficacy in serial evaluations and follow-up of new therapeutic options.

Comparison with previous studies

To the best of our knowledge, this is the first study evaluating LA function in SSc by STE strain analysis. Several reports had previously described subclinical LV and RV abnormalities in SSc patients, using TDI parameters and strain rate imaging [34,35,50-55]. Mele et al. showed that TDI-derived myocardial systolic deformation indices, based on strain and strain rate analysis and E/e’ ratio, are a valuable approach to detecting cardiac involvement in asymptomatic SSc patients [35]. D’Andrea et al. further confirmed that STE imaging can detect both RV and LV early myocardial involvement in SSc, as well as coronary flow reserve and brachial artery flow-mediated dilatation, as signs of early vascular impairment [53]. In another study, Shattke et al. employed isovolumetric acceleration, a novel tissue Doppler parameter, to detect early RV systolic impairment in SSc patients without pulmonary hypertension [51]. Kepez et al. found that SSc patients without pulmonary hypertension and overt clinical cardiac involvement had reduced myocardial strain and strain rate, despite normal 2D, conventional Doppler and TDI parameters [50]. Interestingly, Yiu et al. showed that subtle LV dysfunction, still assessed by STE strain analysis, is related to lower functional capacity and rhythm disturbances in patients with SSc [54]. Recently, Spethmann et al. showed that LV systolic impairment, as assessed by strain imaging, is primarily due to alterations in the basal LV segments in SSc patients with preserved LVEF [55].

All previous studies on speckle tracking in SSc patients never addressed LA function or dimensions, because they were focused on LV or RV function. It is true that assessment of both left and right ventricular dysfunction is the main target of cardiac assessment and represents the final result of all potential pathophysiological impairments. However, many of these alterations can be intercepted earlier by means of changes of the LA regional mechanical characteristics and function. A few previous studies had evaluated LA characteristics in SSc patients: Dimitroulas et al. showed that LA volume may be a useful noninvasive marker for the prediction of elevated pulmonary artery pressure in these patients [56]; impairment of electromechanical LA functions, including a prolonged intra-interatrial electromechanical delay and higher P-wave dispersion was also found in SSc patients, compared to a control group, confirming the increased risk of these patients for developing supraventricular arrhythmias [56].

Study limitations

Some limitations of the present study should be highlighted. The study population was limited in size, since SSc is a relatively rare disease. Additionally, we excluded patients with signs of overt cardiac involvement, which could have affected strain and strain rate measurements. Therefore, our results cannot be extended to patients with heart failure or other concomitant cardiac disease. Finally, the study population was relatively old. It is well known that the occurrence of diastolic dysfunction increases with age. However, age was not different in the two groups, and interestingly, we found a significant correlation between ϵ pos peak and age only in the control group and not in SSc patients. A main limitation is the lack of normal cut-off values for strain imaging. However, two studies report LA strain values in a healthy population, which can be considered as reference values [9,57,58]. Although very promising, a current significant limitation of strain imaging is inter-vendor variability; thus, up-to-date, strain analysis is still confined to the research field and has not yet been implemented in routine clinical practice.


Conclusion

STE is a sensitive tool to assess impairment of LA mechanics, which is detectable in absence of changes in LA size and volume, and may represent an early sign of cardiac involvement in patients with SSc.


Abbreviations

ϵ pos peak: Positive peak left atrial longitudinal strain; sec ϵ pos peak: Second positive peak left atrial longitudinal strain; ϵ neg peak: Negative peak left atrial longitudinal strain; A: Mitral inflow late pulsatile Doppler wave; BSA: Body surface area; E: Mitral inflow early pulsatile Doppler wave; e’: Early diastolic mitral annular velocity; EF: Ejection fraction; LA: Left atrium; LV: Left ventricle; NYHA: New York Heart Association; PASP: Pulmonary artery systolic pressure; SSc: Systemic sclerosis; STE: Two-dimensional speckle tracking echocardiography; TDI: Tissue Doppler imaging.


Competing interests

The authors declare that they have no competing interests (there are not disclosures of any relationship with industry) relevant to the contents of this paper to disclose.


Authors’ contributions

GA, LG, MHM, MC, LPB, AM, DM, SM, AMP, MMC, RS, EP, AV read and approved the final manuscript.


Acknowledgements

The authors would like to thank Gennaro D’Angelo for his help in data processing, Claudia Venneri for her logistical support, and Alison Frank who revised the English version of the manuscript.

Funding

Gergely Agoston was a recipient of a research grant funded by the European Association of Cardiovascular Imaging.

Marcelo Miglioranza received a post-graduate grant from CAPES, a Brazilian governmental agency for post-graduate support.

Denisa Muraru and Luigi P. Badano have received equipment grants from GE Vingmed (Horten, N) and served on the Speakers’ Bureau of this company.


References
Candell-Riera J,Armadans-Gil L,Simeón CP,Castell-Conesa J,Fonollosa-Pla V,García-del-Castillo H,Vaqué-Rafart J,Vilardell M,Soler-Soler J,Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosisArthritis RheumYear: 1996127113811458670322
Follansbee WP,Miller TR,Curtiss EI,Orie JE,Bernstein RL,Kiernan JM,Medsger TA Jr,A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma)J RheumatolYear: 19901256566622359076
Bulkley BH,Ridolfi RL,Salyer WR,Hutchins GM,Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunctionCirculationYear: 19761234834901248080
Kahan A,Allanore Y,Primary myocardial involvement in systemic sclerosisRheumatology (Oxford)Year: 200612Suppl 4iv14iv1716980717
Ioannidis JP,Vlachoyiannopoulos PG,Haidich AB,Medsger TA Jr,Lucas M,Michet CJ,Kuwana M,Yasuoka H,van den Hoogen F,Te Boome L,van Laar JM,Verbeet NL,Matucci-Cerinic M,Georgountzos A,Moutsopoulos HM,Mortality in systemic sclerosis: an international meta-analysis of individual patient dataAm J MedYear: 200512121015639201
Tsang TS,Barnes ME,Bailey KR,Leibson CL,Montgomery SC,Takemoto Y,Diamond PM,Marra MA,Gersh BJ,Wiebers DO,Petty GW,Seward JB,Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and womenMayo Clin ProcYear: 20011246747511357793
Aktoz M,Yilmaztepe M,Tatli E,Turan FN,Umit EG,Altun A,Assessment of ventricular and left atrial mechanical functions, atrial electromechanical delay and P wave dispersion in patients with sclerodermaCardiol JYear: 20111226126921660915
Aktürk E,Yağmur J,Kurtoğlu E,Ermis N,Acikgoz N,Sener S,Karakuş Y,Aktürk S,Karincaoğlu Y,Pekdemir H,Özdemir R,Left atrial volume and function in patients with Behcet’s disease assessed by real-time three-dimensional echocardiographyEur Heart J Cardiovasc ImagingYear: 201212865065522271104
Cameli M,Caputo M,Mondillo S,Ballo P,Palmerini E,Lisi M,Marino E,Galderisi M,Feasibility and reference values of left atrial longitudinal strain imaging by two-dimensional speckle trackingCardiovascular UltrasoundYear: 200912619200402
Cameli M,Lisi M,Mondillo S,Padeletti M,Ballo P,Tsioulpas C,Bernazzali S,Maccherini M,Left atrial longitudinal strain by speckle tracking echocardiography correlates well with left ventricular filling pressures in patients with heart failureCardiovasc UltrasoundYear: 2010121420409332
Clements P,Lachenbruch P,Seibold JR,White B,Weiner S,Martin R,Weinstein A,Weisman M,Mayes M,Collier D,Inter- and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosisJ RheumatolYear: 199512128112857562759
Miller MR,Hankinson J,Brusasco V,Burgos F,Casaburi R,Coates A,Crapo R,Enright P,van der Grinten CPM,Gustafsson P,Jensen R,Johnson DC,MacIntyre N,McKay R,Navajas D,Pedersen OF,Pellegrino R,Viegi G,J Wanger Series ATS/ERS Task Force: Standardisation of lung function testing Edited by V. Brusasco, R. Crapo and GViegi Eur Respir JYear: 2005319338
Gargani L,Doveri M,D’Errico L,Frassi F,Bazzichi ML,Delle Sedie A,Scali MC,Monti S,Mondillo S,Bombardieri S,Caramella D,Picano E,Ultrasound lung comets in systemic sclerosis: a chest sonography hallmark of pulmonary interstitial fibrosisRheumatologyYear: 2009121382138719717549
Desai SR,Veeraraghavan S,Hansell DM,Nikolakopolou A,Goh NS,Nicholson AG,Colby TV,Denton CP,Black CM,du Bois RM,Wells AU,CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumoniaRadiologyYear: 200412256056715286324
Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria CommitteePreliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis RheumYear: 198012581590
Lang RM,Bierig M,Devereux RB,Flachskampf FA,Foster E,Pellikka PA,Picard MH,Roman MJ,Seward J,Shanewise J,Solomon S,Spencer KT,St John Sutton M,Stewart W,American Society of Echocardiography’s Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography; European Society of CardiologyRecommendations for chamber quantificationEur J EchocardiogrYear: 20061227910816458610
Lancellotti P,Moura L,Pierard LA,Agricola E,Popescu BA,Tribouilloy C,Hagendorff A,Monin JL,Badano L,Zamorano JL,on behalf of the European Association of Echocardiography European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)Eur J EchocardiogrYear: 20101230733220435783
Nagueh SF,Appleton CP,Gillebert TC,Marino PN,Oh JK,Smiseth OA,Waggoner AD,Flachskampf FA,Pellikka PA,Evangelista A,Recommendations for the evaluation of left ventricular diastolic function by echocardiographyEur J EchocardiogrYear: 20091216519319270053
Rudski LG,Lai WW,Afilal J,Hua L,Handschumacher MD,Chandrasekaran K,Solomon SD,Louie EK,Schiller NB,Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of EchocardiographyJ Am Soc EchocardiogrYear: 2010127685713 quiz 786–8. 20620859
Mor-Avi V,Lang RM,Badano LP,Belohlavek M,Cardim NM,Derumeaux G,Galderisi M,Marwick T,Nagueh SF,Sengupta PP,Sicari R,Smiseth OA,Smulevitz B,Takeuchi M,Thomas JD,Vannan M,Voigt JU,Zamorano JL,Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of EchocardiographyEur J EchocardiogrYear: 201112316720521385887
Serri K,Reant P,Lafitte M,Berhouet M,Le Bouffos V,Roudaut R,Lafitte S,Global and regional myocardial function quantification by two dimensional strainJ Am Coll CardiolYear: 2006121175118116545649
Rossi A,Zardini P,Marino P,Modulation of left atrial function by ventricular filling impairmentHeart Fail RevYear: 20001232533111498645
Kono T,Sabbah HN,Rosman H,Alam M,Stein PD,Goldstein S,Left atrial contribution to ventricular filling during the course of evolving heart failureCirculationYear: 199212131713221394938
Prioli A,Marino P,Lanzoni L,Zardini P,Increasing degrees of left ventricular filling impairment modulate left atrial function in humansAm J CardiolYear: 1998127567619761086
Tsang TS,Barnes ME,Gersh BJ,Bailey KR,Seward JB,Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burdenAm J CardiolYear: 2002121284128912480035
Benjamin EJ,D’Agostino RB,Belanger AJ,Wolf PA,Levy D,Left atrial size and the risk of stroke and death. The Framingham Heart StudyCirculationYear: 1995128358417641364
Inaba Y,Yuda S,Kobayashi N,Hashimoto A,Uno K,Nakata T,Tsuchihashi K,Miura T,Ura N,Shimamoto K,Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls andpatients with atrial fibrillationJ Am Soc EchocardiogrYear: 200512772973616003270
Thomas L,McKay T,Byth K,Marwick TH,Abnormalities of left atrial function after cardioversion: an atrial strain rate studyHeartYear: 2007121899516818487
Cameli M,Lisi M,Reccia R,Bennati E,Malandrino A,Solari M,Bigio E,Biagioli B,Righini FM,Maccherini M,Chiavarelli M,Henein M,Mondillo S,Pre-operative left atrial strain predicts post-operative atrial fibrillation in patients undergoing aortic valve replacement for aortic stenosisInt J Cardiovasc ImagingYear: 201412227928624202403
Cameli M,Lisi M,Righini FM,Mondillo S,Novel echocardiographic techniques to assess left atrial size, anatomy and functionCardiovasc UltrasoundYear: 201212422296702
Kahan A,Nitenberg A,Foult JM,Amor B,Menkes CJ,Devaux JY,Blanchet F,Perennec J,Lutfalla G,Roucayrol JC,Decreased coronary reserve in primary scleroderma myocardial diseaseArthritis RheumYear: 1985126376464004974
Gustafsson R,Mannting F,Kazzam E,Waldenström A,Hällgren R,Cold-induced reversible myocardial ischaemia in systemic sclerosisLancetYear: 19891286614754792570187
Valentini G,Vitale DF,Giunta A,Maione S,Gerundo G,Arnese M,Tirri E,Pelaggi N,Giacummo A,Tirri G,Condorelli M,Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserveAnn Rheum DisYear: 19961274554608774164
Meune C,Avouac J,Wahbi K,Cabanes L,Wipff J,Mouthon L,Guillevin L,Kahan A,Allanore Y,Cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography during routine care: a controlled study of 100 consecutive patientsArthritis RheumYear: 20081261803180918512815
Mele D,Censi S,La Corte R,Merli E,Lo Monaco A,Locaputo A,Ceconi C,Trotta F,Ferrari R,Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using Doppler measures of myocardial strainJ Am Soc EchocardiogrYear: 200812111257126418992677
Armstrong GP,Whalley GA,Doughty RN,Gamble GD,Flett SM,Tan PL,Sharpe DN Left ventricular function in sclerodermaBr J RheumatolYear: 199612109839888883437
Ferri C1,Giuggioli D,Sebastiani M,Colaci M,Emdin M,Heart involvement and systemic sclerosisLupusYear: 20051270270716218471
Tzelepis GE,Kelekis NL,Plastiras SC,Mitseas P,Economopoulos N,Kampolis C,Gialafos EJ,Moyssakis I,Moutsopoulos HM,Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhancement magnetic resonance imaging studyArthritis and RheumatismYear: 2007123827383617968945
Di Cesare E,Battisti S,Di Sibio A,Cipriani P,Giacomelli R,Liakouli V,Ruscitti P,Masciocchi C,Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI)Eur J RadiolYear: 2013126e268e27323510727
Hachulla A-L,Launay D,Gaxotte V,de Groote P,Lamblin N,Devos P,Hatron PY,Beregi JP,Hachulla E,Cardiac magnetic resonance imaging in sistemic sclerosis: a cross-sectional observational study of 52 patientsAnnals of the Rheumatic DiseasesYear: 2009121878188419054830
Nassenstein K,Breuckmann F,Huger M,Ladd SC,Schlosser T,Kreuter A,Barkhausen J,Detection of myocardial fibrosis in systemic sclerosis by contrast-enhanced magnetic resonance imagingFortschr RontgenstrYear: 20081210541060
D’Angelo WA,Fries JF,Masi AT,Shulman LE,Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controlsAm J MedYear: 19691234284405780367
Mavrogeni S,Bratis K,Sfikakis PP,Pleuro pericarditis, vasculitis, subendocardial and nodular biventricular fibrosis. The multiple faces of systemic sclerosis detected by cardiac magnetic resonance in the same patientInt J CardiolYear: 2013122e26e2722959868
Mavrogeni S,Bratis K,van Wijk K,Stavropoulos E,Hautemann D,Reiber JH,Kolovou G,Myocardial perfusion-fibrosis pattern in systemic sclerosis assessed by cardiac magnetic resonanceInt J CardiolYear: 2012123e56e5822227256
Ntusi NA,Piechnik SK,Francis JM,Ferreira VM,Rai AB,Matthews PM,Robson MD,Moon J,Wordsworth PB,Neubauer S,Karamitsos TD,Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis–a clinical study using myocardial T1-mapping and extracellular volume quantificationJ Cardiovasc Magn ResonYear: 2014122124593856
Leung DY,Boyd A,Ng AA,Chi C,Thomas L,Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implicationsAm Heart JYear: 20081261056106419032999
Rosca M,Lancellotti P,Popescu BA,Piérard LA,Left atrial function: pathophysiology, echocardiographic assessment, and clinical applicationsHeartYear: 201112231982198922058287
Vaziri SM,Larson MG,Benjamin EJ,Levy D,Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart StudyCirculationYear: 199212724730
Cameli M,Lisi M,Righini FM,Massoni A,Natali BM,Focardi M,Tacchini D,Geyer A,Curci V,Di Tommaso C,Lisi G,Maccherini M,Chiavarelli M,Massetti M,Tanganelli P,Mondillo S,Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapseAm J CardiolYear: 201312459560123211360
Kepez A,Akdogan A,Sade LE,Deniz A,Kalyoncu U,Karadag O,Hayran M,Aytemir K,Ertenli I,Kiraz S,Calguneri M,Kabakci G,Tokgozoglu L,Detection of subclinical cardiac involvement in systemic sclerosis by echocardiographic strain imagingEchocardiographyYear: 200812219119718269564
Schattke S,Knebel F,Grohmann A,Dreger H,Kmezik F,Riemekasten G,Baumann G,Borges AC,Early right ventricular systolic dysfunction in patients with systemic sclerosis without pulmonary hypertension: a Doppler Tissue and Speckle Tracking echocardiography studyCardiovasc UltrasoundYear: 201012320096122
Matias C,Isla LP,Vasconcelos M,Almería C,Rodrigo JL,Serra V,Zamorano JL,Speckle-tracking-derived strain and strain-rate analysis: a technique for the evaluation of early alterations in right ventricle systolic function in patients with systemic sclerosis and normal pulmonary artery pressureJ Cardiovasc Med (Hagerstown)Year: 20091212913419194173
D’Andrea A,Stisi S,Bellissimo S,Vigorito F,Scotto di Uccio F,Tozzi N,Moscato F,Pezzullo E,Calabrò R,Scherillo M,Early impairment of myocardial function in systemic sclerosis: non-invasive assessment by Doppler myocardial and strain rate imagingEur J EchocardiogrYear: 20051240741816293527
Yiu KH,Schouffoer AA,Marsan NA,Ninaber MK,Stolk J,Vlieland TV,Scherptong RW,Delgado V,Holman ER,Tse HF,Huizinga TW,Bax JJ,Schuerwegh AJ,Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmiasArthritis RheumYear: 201112123969397822127711
Spethmann S,Dreger H,Schattke S,Riemekasten G,Borges AC,Baumann G,Knebel F,Two-dimensional speckle tracking of the left ventricle in patients with systemic sclerosis for an early detection of myocardial involvementEur Heart J Cardiovasc ImagingYear: 20121286387022427402
Dimitroulas T,Giannakoulas G,Papadopoulou K,Sfetsios T,Karvounis H,Dimitroula H,Parcharidou D,Koliakos G,Garyfallos A,Styliadis I,Settas L,Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosisClin RheumatolYear: 20101295796420526641
Vianna-Pinton R,Moreno CA,Baxter CM,Lee KS,Tsang TS,Appleton CP,Twodimensional speckle-tracking echocardiography of the left atrium: feasibility and regional contraction and relaxation differences in normal subjectsJ Am Soc EchocardiographyYear: 200912299305
Saraiva RM,Demirkol S,Buakhamsri A,Greenberg N,Popovic ZB,Thomas JD,Klein AL,Left atrial strain measured by two-dimensional speckle tracking represents a new tool to evaluate left atrial functionJ Am Soc EchocardiographyYear: 201012172180

Figures

[Figure ID: F1]
Figure 1 

2D speckle tracking derived LA peak, positive longitudinal strain (ϵ pos peak)measurement form apical 4 chamber view (the reference point is the beginning of the QRS complex).



[Figure ID: F2]
Figure 2 

Measurement of second positive peak longitudinal LA strain (sec ϵpos peak) and negative peak longitudinal strain (ϵneg peak) from apical four chamber view (the reference point is the onset of the p wave).



[Figure ID: F3]
Figure 3 

Differences in the indexed left atrial volume between SSc and control patients.



[Figure ID: F4]
Figure 4 

Differences in E/e’ between SSc and control patients.



[Figure ID: F5]
Figure 5 

Differences in peak positive LA longitudinal strain (ϵ pos peak) between SSc and control patients.



Tables
[TableWrap ID: T1] Table 1 

Clinical characteristics


Clinical variables Group 1 (SSc) 42 pts Group 2 (Controls) 42 pts p
Age (years)
50 ± 14
49 ± 13
ns
Female gender (n,%)
40 (95%)
40 (95%)
ns
Systemic arterial hypertension (n,%)
10 (24%)
16 (38%)
ns
Diabetes (n,%)
0 (0%)
1 (2%)
ns
History of Smoking (n,%)
3 (7%)
6 (14%)
ns
Limited form n (%)
35 (83%)
 
 
Diffuse form n (%)
7 (17%)
 
 
Scl-70 antibodies n(%)
13 (31%)
 
 
DLCO (%)
80.6 ± 23.2
 
 
NTpro-BNP (pg/ml) 122 ± 135    

SSc: systemic sclerosis.

DLCO_ diffusing capacity of carbon monoxide.

NTpro-BNP- N-terminal B-type natriuretic peptide.


[TableWrap ID: T2] Table 2 

Echocardiographic data


Echo variables Group 1 (SSc) 42 pts Group 2 (Controls) 42 pts p
EF (%)
63.1 ± 4
66.1 ± 4
ns
LA indexed volumes (ml/m2)
24.9 ± 5.3
24.7 ± 4.4
ns
E/A
1.1 ± 0.4
1.3 ± 0.4
ns
E/e’
7.6 ± 2.4
6.5 ± 1.7
p˂0.05
PASP (mmHg)
24.1 ± 8
21 ± 7
ns
sec ϵ pos peak (%)
18.4 ± 4
21.4 ± 7.6
p˂0.05
ϵ neg peak (%)
-12.9 ± 2
-13.6 ± 3
ns
ϵ pos peak (%) 31.3 ± 4.2 35 ± 7.6 p˂0.01

ϵ pos peak: positive peak left atrial longitudinal strain; sec ϵ pos peak: second positive peak left atrial longitudinal strain; ϵ neg peak – negative peak left atrial longitudinal strain; A: mitral inflow late pulsatile Doppler wave; E: mitral inflow early pulsatile Doppler wave; e’: early diastolic mitral annular velocity; EF: ejection fraction; LA: left atrium; PASP: pulmonary artery systolic pressure; SSc: systemic sclerosis.



Article Categories:
  • Research


Previous Document:  Primary leiomyosarcoma of a horseshoe kidney in a woman with Turner syndrome: a case report.
Next Document:  Construction of a Streptococcus iniae sortase A mutant and evaluation of its potential as an attenua...